| (210) | Number of the EPO application | 16769872 |
| (220) | Filing date of the EPO application | 2016.08.26 |
| (80) | EPO patent specification publication (B) | EPB nr. 46/2019, 2019.11.13 |
| (110) | EPO patent number | 3341380 |
| (21) | Number of the application | e 2018 0653 |
| (71) | Name(s) of applicant(s), code of the country | Prexton Therapeutics SA, CH; |
| (72) | Name(s) of inventor(s), code of the country | CHARVIN Delphine, FR;
CONQUET François, FR; |
| (73) | Name(s) of owner(s), code of the country | PREXTON Therapeutics SA, CH; |
| (54) | Title of the invention | BRAIN-PENETRANT CHROMONE OXIME DERIVATIVE FOR THE THERAPY OF LEVODOPA-INDUCED DYSKINESIA |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 495/04 (2006.01.01); A61K 31/407 (2006.01.01); A61P 25/16 (2006.01.01) |
| (19) | Country | CH |
| (41) | Date of publication of the application | 2018.08.31 |
| (30) | Priority | PCT/EP2015/0696, 2015.08.27, WO; 15188368, 2015.10.05, EP |
| (86) | International application | PCT/EP2016/070175, 2016.08.26 |
| (87) | International publication | WO 2017/032874, 2017.03.02 |